Jiangsu Ebitda vs Research Development Analysis

688670 Stock

16.68 0.39 2.39%

Jiangsu GDK financial indicator trend analysis is infinitely more than just investigating Jiangsu GDK Biotechnology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jiangsu GDK Biotechnology is a good investment. Please check the relationship between Jiangsu GDK Ebitda and its Research Development accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu GDK Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Ebitda vs Research Development

Ebitda vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jiangsu GDK Biotechnology Ebitda account and Research Development. At this time, the significance of the direction appears to have strong relationship.

The correlation between Jiangsu GDK's Ebitda and Research Development is 0.7. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Research Development in the same time period over historical financial statements of Jiangsu GDK Biotechnology, assuming nothing else is changed. The correlation between historical values of Jiangsu GDK's Ebitda and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Jiangsu GDK Biotechnology are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Ebitda i.e., Jiangsu GDK's Ebitda and Research Development go up and down completely randomly.

Correlation Coefficient

0.7

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ebitda

Research Development

Most indicators from Jiangsu GDK's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jiangsu GDK Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu GDK Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 95.1 M, whereas Tax Provision is projected to grow to (14.8 M).

	2021	2022	2023	2024 (projected)
Interest Expense	9.9M	1.3M	1.9M	1.8M
Depreciation And Amortization	28.1M	29.8M	34.2M	31.6M

Interest Expense Depreciation And Amortization

Jiangsu GDK fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Common Stock Shares Outstanding	Net Receivables	Short Term Investments	Net Invested Capital	Short Long Term Debt
Total Assets		0.09	-0.81	-0.54	0.96	0.93	-0.63	0.93	0.86	0.81	0.95	0.53	0.95	0.92	0.84	0.45	-0.37	0.98	0.09	0.89	0.97	0.87	0.7	0.88	0.99	-0.05
Short Long Term Debt Total	0.09		-0.24	0.6	0.04	-0.11	0.55	0.36	-0.21	0.39	-0.12	-0.14	0.04	-0.02	0.54	0.06	0.65	0.21	1.0	0.23	0.13	0.14	0.49	-0.1	0.13	0.98
Other Current Liab	-0.81	-0.24		0.6	-0.81	-0.75	0.42	-0.89	-0.72	-0.69	-0.74	-0.41	-0.79	-0.73	-0.61	-0.44	0.48	-0.82	-0.24	-0.61	-0.84	-0.77	-0.65	-0.69	-0.84	-0.17
Total Current Liabilities	-0.54	0.6	0.6		-0.62	-0.65	0.79	-0.4	-0.68	-0.13	-0.66	-0.41	-0.63	-0.53	-0.01	-0.47	0.98	-0.44	0.6	-0.3	-0.56	-0.53	0.0	-0.6	-0.55	0.64
Total Stockholder Equity	0.96	0.04	-0.81	-0.62		0.91	-0.72	0.91	0.85	0.75	0.93	0.48	0.99	0.88	0.77	0.62	-0.48	0.93	0.04	0.87	0.94	0.87	0.57	0.88	0.98	-0.11
Property Plant And Equipment Net	0.93	-0.11	-0.75	-0.65	0.91		-0.81	0.78	0.98	0.77	0.99	0.28	0.88	0.77	0.64	0.56	-0.53	0.84	-0.11	0.85	0.94	0.92	0.45	0.72	0.92	-0.23
Net Debt	-0.63	0.55	0.42	0.79	-0.72	-0.81		-0.41	-0.86	-0.41	-0.81	-0.11	-0.71	-0.55	-0.22	-0.61	0.75	-0.49	0.55	-0.56	-0.61	-0.65	0.03	-0.55	-0.63	0.65
Retained Earnings	0.93	0.36	-0.89	-0.4	0.91	0.78	-0.41		0.71	0.83	0.8	0.52	0.89	0.88	0.89	0.4	-0.23	0.97	0.36	0.8	0.9	0.78	0.82	0.84	0.95	0.23
Accounts Payable	0.86	-0.21	-0.72	-0.68	0.85	0.98	-0.86	0.71		0.76	0.96	0.18	0.81	0.73	0.53	0.5	-0.58	0.76	-0.21	0.75	0.86	0.85	0.39	0.66	0.85	-0.31
Cash	0.81	0.39	-0.69	-0.13	0.75	0.77	-0.41	0.83	0.76		0.75	0.09	0.69	0.71	0.83	0.27	0.02	0.8	0.39	0.77	0.76	0.71	0.75	0.57	0.8	0.28
Non Current Assets Total	0.95	-0.12	-0.74	-0.66	0.93	0.99	-0.81	0.8	0.96	0.75		0.35	0.91	0.8	0.67	0.56	-0.53	0.87	-0.12	0.88	0.95	0.92	0.46	0.77	0.94	-0.25
Non Currrent Assets Other	0.53	-0.14	-0.41	-0.41	0.48	0.28	-0.11	0.52	0.18	0.09	0.35		0.5	0.71	0.41	-0.12	-0.27	0.61	-0.14	0.3	0.45	0.19	0.57	0.81	0.5	-0.23
Cash And Short Term Investments	0.95	0.04	-0.79	-0.63	0.99	0.88	-0.71	0.89	0.81	0.69	0.91	0.5		0.86	0.76	0.65	-0.49	0.92	0.04	0.87	0.93	0.87	0.53	0.87	0.97	-0.12
Non Current Liabilities Total	0.92	-0.02	-0.73	-0.53	0.88	0.77	-0.55	0.88	0.73	0.71	0.8	0.71	0.86		0.75	0.18	-0.34	0.94	-0.02	0.69	0.81	0.61	0.78	0.98	0.89	-0.17
Inventory	0.84	0.54	-0.61	-0.01	0.77	0.64	-0.22	0.89	0.53	0.83	0.67	0.41	0.76	0.75		0.31	0.16	0.89	0.54	0.86	0.8	0.69	0.82	0.69	0.84	0.38
Other Current Assets	0.45	0.06	-0.44	-0.47	0.62	0.56	-0.61	0.4	0.5	0.27	0.56	-0.12	0.65	0.18	0.31		-0.5	0.36	0.06	0.6	0.56	0.75	-0.16	0.24	0.53	-0.02
Total Liab	-0.37	0.65	0.48	0.98	-0.48	-0.53	0.75	-0.23	-0.58	0.02	-0.53	-0.27	-0.49	-0.34	0.16	-0.5		-0.26	0.65	-0.16	-0.42	-0.44	0.2	-0.42	-0.39	0.66
Total Current Assets	0.98	0.21	-0.82	-0.44	0.93	0.84	-0.49	0.97	0.76	0.8	0.87	0.61	0.92	0.94	0.89	0.36	-0.26		0.21	0.86	0.94	0.8	0.81	0.91	0.97	0.06
Short Term Debt	0.09	1.0	-0.24	0.6	0.04	-0.11	0.55	0.36	-0.21	0.39	-0.12	-0.14	0.04	-0.02	0.54	0.06	0.65	0.21		0.23	0.13	0.14	0.49	-0.1	0.13	0.98
Intangible Assets	0.89	0.23	-0.61	-0.3	0.87	0.85	-0.56	0.8	0.75	0.77	0.88	0.3	0.87	0.69	0.86	0.6	-0.16	0.86	0.23		0.91	0.9	0.53	0.67	0.9	0.09
Common Stock	0.97	0.13	-0.84	-0.56	0.94	0.94	-0.61	0.9	0.86	0.76	0.95	0.45	0.93	0.81	0.8	0.56	-0.42	0.94	0.13	0.91		0.95	0.61	0.78	0.97	0.0
Common Stock Shares Outstanding	0.87	0.14	-0.77	-0.53	0.87	0.92	-0.65	0.78	0.85	0.71	0.92	0.19	0.87	0.61	0.69	0.75	-0.44	0.8	0.14	0.9	0.95		0.38	0.58	0.89	0.04
Net Receivables	0.7	0.49	-0.65	0.0	0.57	0.45	0.03	0.82	0.39	0.75	0.46	0.57	0.53	0.78	0.82	-0.16	0.2	0.81	0.49	0.53	0.61	0.38		0.69	0.67	0.39
Short Term Investments	0.88	-0.1	-0.69	-0.6	0.88	0.72	-0.55	0.84	0.66	0.57	0.77	0.81	0.87	0.98	0.69	0.24	-0.42	0.91	-0.1	0.67	0.78	0.58	0.69		0.87	-0.25
Net Invested Capital	0.99	0.13	-0.84	-0.55	0.98	0.92	-0.63	0.95	0.85	0.8	0.94	0.5	0.97	0.89	0.84	0.53	-0.39	0.97	0.13	0.9	0.97	0.89	0.67	0.87		-0.01
Short Long Term Debt	-0.05	0.98	-0.17	0.64	-0.11	-0.23	0.65	0.23	-0.31	0.28	-0.25	-0.23	-0.12	-0.17	0.38	-0.02	0.66	0.06	0.98	0.09	0.0	0.04	0.39	-0.25	-0.01

Click cells to compare fundamentals

Jiangsu GDK Account Relationship Matchups

Jiangsu GDK fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	397.3M	778.0M	1.8B	1.8B	1.6B	1.1B
Short Long Term Debt Total	56.9M	296.7M	10.0M	42.0M	48.3M	85.4M
Other Current Liab	405.6M	187.2M	153.2M	161.5M	145.4M	199.2M
Total Current Liabilities	488.6M	509.1M	221.7M	302.5M	227.3M	282.6M
Total Stockholder Equity	(108.4M)	242.5M	1.5B	1.5B	1.4B	1.4B
Property Plant And Equipment Net	192.8M	193.1M	523.9M	785.9M	794.9M	458.8M
Net Debt	49.4M	208.7M	(26.7M)	(132.7M)	(119.4M)	(113.4M)
Retained Earnings	(158.4M)	126.2M	200.4M	193.8M	105.2M	110.5M
Accounts Payable	26.1M	25.1M	58.5M	98.9M	86.7M	58.1M
Cash	7.6M	88.0M	36.7M	174.7M	70.4M	59.9M
Non Current Assets Total	302.0M	255.2M	684.8M	875.8M	909.4M	567.3M
Non Currrent Assets Other	3.8M	5.8M	81.2M	5.5M	3.4M	3.2M
Cash And Short Term Investments	16.7M	128.0M	694.0M	565.3M	650.1M	682.6M
Liabilities And Stockholders Equity	397.3M	778.0M	1.8B	1.8B	2.1B	2.2B
Non Current Liabilities Total	17.1M	26.4M	71.4M	64.6M	33.2M	39.2M
Inventory	18.4M	33.3M	28.0M	32.0M	22.0M	21.6M
Total Liab	505.7M	535.5M	293.1M	367.1M	260.5M	311.1M
Total Current Assets	95.3M	522.8M	1.1B	951.0M	722.2M	532.3M
Short Term Debt	56.9M	296.7M	10.0M	42.0M	48.3M	85.4M
Intangible Assets	48.5M	49.5M	57.9M	66.6M	77.5M	58.5M
Common Stock Shares Outstanding	50.1M	65.9M	75.0M	88.4M	123.2M	83.0M

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

Other Information on Investing in Jiangsu Stock

Balance Sheet is a snapshot of the financial position of Jiangsu GDK Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Jiangsu GDK Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jiangsu GDK and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jiangsu currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jiangsu Ebitda vs Research Development Analysis

Ebitda vs Research Development

Ebitda vs Research Development Correlation Analysis

Correlation Coefficient

Ebitda

Research Development

Jiangsu GDK fundamental ratios Correlations

Jiangsu GDK Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Jiangsu GDK fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Jiangsu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 1.0	Short Long Term Debt Total
Net Invested Capital	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Stockholder Equity
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.98	Total Assets
Short Long Term Debt	+ 0.98	Short Long Term Debt Total

Retained Earnings	- 0.89	Other Current Liab
Accounts Payable	- 0.86	Net Debt
Net Invested Capital	- 0.84	Other Current Liab
Common Stock	- 0.84	Other Current Liab
Total Current Assets	- 0.82	Other Current Liab
Non Current Assets Total	- 0.81	Net Debt